CAR T Cells Drive Outcomes in MM – MedPage Today
|
CAR T Cells Drive Outcomes in MM
MedPage Today CHICAGO — Engineered immune cells showed promise in relapsed and refractory multiple myeloma, with two studies demonstrating impressive, but early, results. Researchers from China reported that T cells modified to track and kill multiple myeloma cells … |
